Cargando…

Diagnosis prediction of tumours of unknown origin using ImmunoGenius, a machine learning-based expert system for immunohistochemistry profile interpretation

BACKGROUND: Immunohistochemistry (IHC) remains the gold standard for the diagnosis of pathological diseases. This technique has been supporting pathologists in making precise decisions regarding differential diagnosis and subtyping, and in creating personalized treatment plans. However, the interpre...

Descripción completa

Detalles Bibliográficos
Autores principales: Chong, Yosep, Thakur, Nishant, Lee, Ji Young, Hwang, Gyoyeon, Choi, Myungjin, Kim, Yejin, Yu, Hwanjo, Cho, Mee Yon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953791/
https://www.ncbi.nlm.nih.gov/pubmed/33706755
http://dx.doi.org/10.1186/s13000-021-01081-8
_version_ 1783663985883611136
author Chong, Yosep
Thakur, Nishant
Lee, Ji Young
Hwang, Gyoyeon
Choi, Myungjin
Kim, Yejin
Yu, Hwanjo
Cho, Mee Yon
author_facet Chong, Yosep
Thakur, Nishant
Lee, Ji Young
Hwang, Gyoyeon
Choi, Myungjin
Kim, Yejin
Yu, Hwanjo
Cho, Mee Yon
author_sort Chong, Yosep
collection PubMed
description BACKGROUND: Immunohistochemistry (IHC) remains the gold standard for the diagnosis of pathological diseases. This technique has been supporting pathologists in making precise decisions regarding differential diagnosis and subtyping, and in creating personalized treatment plans. However, the interpretation of IHC results presents challenges in complicated cases. Furthermore, rapidly increasing amounts of IHC data are making it even harder for pathologists to reach to definitive conclusions. METHODS: We developed ImmunoGenius, a machine-learning-based expert system for the pathologist, to support the diagnosis of tumors of unknown origin. Based on Bayesian theorem, the most probable diagnoses can be drawn by calculating the probabilities of the IHC results in each disease. We prepared IHC profile data of 584 antibodies in 2009 neoplasms based on the relevant textbooks. We developed the reactive native mobile application for iOS and Android platform that can provide 10 most possible differential diagnoses based on the IHC input. RESULTS: We trained the software using 562 real case data, validated it with 382 case data, tested it with 164 case data and compared the precision hit rate. Precision hit rate was 78.5, 78.0 and 89.0% in training, validation and test dataset respectively. Which showed no significant difference. The main reason for discordant precision was lack of disease-specific IHC markers and overlapping IHC profiles observed in similar diseases. CONCLUSION: The results of this study showed a potential that the machine-learning algorithm based expert system can support the pathologic diagnosis by providing second opinion on IHC interpretation based on IHC database. Incorporation with contextual data including the clinical and histological findings might be required to elaborate the system in the future. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13000-021-01081-8.
format Online
Article
Text
id pubmed-7953791
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79537912021-03-15 Diagnosis prediction of tumours of unknown origin using ImmunoGenius, a machine learning-based expert system for immunohistochemistry profile interpretation Chong, Yosep Thakur, Nishant Lee, Ji Young Hwang, Gyoyeon Choi, Myungjin Kim, Yejin Yu, Hwanjo Cho, Mee Yon Diagn Pathol Research BACKGROUND: Immunohistochemistry (IHC) remains the gold standard for the diagnosis of pathological diseases. This technique has been supporting pathologists in making precise decisions regarding differential diagnosis and subtyping, and in creating personalized treatment plans. However, the interpretation of IHC results presents challenges in complicated cases. Furthermore, rapidly increasing amounts of IHC data are making it even harder for pathologists to reach to definitive conclusions. METHODS: We developed ImmunoGenius, a machine-learning-based expert system for the pathologist, to support the diagnosis of tumors of unknown origin. Based on Bayesian theorem, the most probable diagnoses can be drawn by calculating the probabilities of the IHC results in each disease. We prepared IHC profile data of 584 antibodies in 2009 neoplasms based on the relevant textbooks. We developed the reactive native mobile application for iOS and Android platform that can provide 10 most possible differential diagnoses based on the IHC input. RESULTS: We trained the software using 562 real case data, validated it with 382 case data, tested it with 164 case data and compared the precision hit rate. Precision hit rate was 78.5, 78.0 and 89.0% in training, validation and test dataset respectively. Which showed no significant difference. The main reason for discordant precision was lack of disease-specific IHC markers and overlapping IHC profiles observed in similar diseases. CONCLUSION: The results of this study showed a potential that the machine-learning algorithm based expert system can support the pathologic diagnosis by providing second opinion on IHC interpretation based on IHC database. Incorporation with contextual data including the clinical and histological findings might be required to elaborate the system in the future. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13000-021-01081-8. BioMed Central 2021-03-11 /pmc/articles/PMC7953791/ /pubmed/33706755 http://dx.doi.org/10.1186/s13000-021-01081-8 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Chong, Yosep
Thakur, Nishant
Lee, Ji Young
Hwang, Gyoyeon
Choi, Myungjin
Kim, Yejin
Yu, Hwanjo
Cho, Mee Yon
Diagnosis prediction of tumours of unknown origin using ImmunoGenius, a machine learning-based expert system for immunohistochemistry profile interpretation
title Diagnosis prediction of tumours of unknown origin using ImmunoGenius, a machine learning-based expert system for immunohistochemistry profile interpretation
title_full Diagnosis prediction of tumours of unknown origin using ImmunoGenius, a machine learning-based expert system for immunohistochemistry profile interpretation
title_fullStr Diagnosis prediction of tumours of unknown origin using ImmunoGenius, a machine learning-based expert system for immunohistochemistry profile interpretation
title_full_unstemmed Diagnosis prediction of tumours of unknown origin using ImmunoGenius, a machine learning-based expert system for immunohistochemistry profile interpretation
title_short Diagnosis prediction of tumours of unknown origin using ImmunoGenius, a machine learning-based expert system for immunohistochemistry profile interpretation
title_sort diagnosis prediction of tumours of unknown origin using immunogenius, a machine learning-based expert system for immunohistochemistry profile interpretation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953791/
https://www.ncbi.nlm.nih.gov/pubmed/33706755
http://dx.doi.org/10.1186/s13000-021-01081-8
work_keys_str_mv AT chongyosep diagnosispredictionoftumoursofunknownoriginusingimmunogeniusamachinelearningbasedexpertsystemforimmunohistochemistryprofileinterpretation
AT thakurnishant diagnosispredictionoftumoursofunknownoriginusingimmunogeniusamachinelearningbasedexpertsystemforimmunohistochemistryprofileinterpretation
AT leejiyoung diagnosispredictionoftumoursofunknownoriginusingimmunogeniusamachinelearningbasedexpertsystemforimmunohistochemistryprofileinterpretation
AT hwanggyoyeon diagnosispredictionoftumoursofunknownoriginusingimmunogeniusamachinelearningbasedexpertsystemforimmunohistochemistryprofileinterpretation
AT choimyungjin diagnosispredictionoftumoursofunknownoriginusingimmunogeniusamachinelearningbasedexpertsystemforimmunohistochemistryprofileinterpretation
AT kimyejin diagnosispredictionoftumoursofunknownoriginusingimmunogeniusamachinelearningbasedexpertsystemforimmunohistochemistryprofileinterpretation
AT yuhwanjo diagnosispredictionoftumoursofunknownoriginusingimmunogeniusamachinelearningbasedexpertsystemforimmunohistochemistryprofileinterpretation
AT chomeeyon diagnosispredictionoftumoursofunknownoriginusingimmunogeniusamachinelearningbasedexpertsystemforimmunohistochemistryprofileinterpretation